Cite
Xu YC, Liu X, Li M, et al. A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID. Mol Ther Nucleic Acids. 2018;12:578-590doi: 10.1016/j.omtn.2018.06.011.
Xu, Y. C., Liu, X., Li, M., Li, Y., Li, C. Y., Lu, Y., Sanches, J., Wang, L., Du, Y., Mao, L. M., Zuo, S. B., Liu, H. T., Shen, J., Wang, B., Hou, L., Li, L. H., Tang, J. W., Ju, J. F., Guan, H. W., & Song, B. (2018). A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID. Molecular therapy. Nucleic acids, 12578-590. https://doi.org/10.1016/j.omtn.2018.06.011
Xu, Yun-Chao, et al. "A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID." Molecular therapy. Nucleic acids vol. 12 (2018): 578-590. doi: https://doi.org/10.1016/j.omtn.2018.06.011
Xu YC, Liu X, Li M, Li Y, Li CY, Lu Y, Sanches J, Wang L, Du Y, Mao LM, Zuo SB, Liu HT, Shen J, Wang B, Hou L, Li LH, Tang JW, Ju JF, Guan HW, Song B. A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID. Mol Ther Nucleic Acids. 2018 Sep 07;12:578-590. doi: 10.1016/j.omtn.2018.06.011. Epub 2018 Jul 05. PMID: 30195794; PMCID: PMC6077131.
Copy
Download .nbib